Structural and Functional Studies of the TRPM4 and TRPM5 Channels

Northwestern University At Chicago, Evanston IL

Investigators

Linked publications & trials

Abstract

PROJECT SUMMARY Blood flow from the heart to the brain is strictly regulated to protect the delicate brain tissue, because improper blood flow can give rise to numerous cardiovascular diseases and brain injuries. TRPM4 is one of the major actors regulating blood flow in the vascular smooth muscle cells in the cerebral arteries when intracellular pressure changes. Mutation or dysfunction of TRPM4 is linked to numerous cardiovascular diseases, including stroke and Brugada syndrome. TRPM4 and its closest homolog, TRPM5, are Ca2+-activated, nonselective, voltage-gated ion channels. TRPM5 is highly expressed in pancreatic beta cells, and dysfunction or mutation in TRPM5 is associated in type II diabetes and obesity. In addition, TRPM4 and TRPM5 in the taste bud cells play an important role in taste signaling, and loss of both channels abolishes the ability to detect bitter, sweet, or umami stimuli. Both channels are modulated by temperature. Taken together, TRPM4 and TRPM5 have a wide range of roles in physiology and pathophysiology. Both TRPM4 and TRPM5 belong to the TRPM (melastatin-like transient receptor potential) subfamily of the TRP superfamily, and they are the only two members impermeable to Ca2+. Over the past four years, our research group, along with others, has made significant progress in elucidating the cryo-EM structures of TRPM4 and TRPM5, paving a solid foundation for uncovering the ligand-dependent molecular mechanisms of TRPM4 and TRPM5 activation and inhibition. However, we still do not understand, in molecular detail, how the channels are modulated by temperature, how they are modulated by small molecules binding to them at specific sites at physiological temperature, how they are distinguished by various drugs, or how their channel functions are modulated by other proteins such as calmodulin. We propose to continue the cryo-EM studies of TRPM4 and TRPM5 and their pharmacology, combined with complementary electrophysiology experiments and collaboration with Takeda. The outcome of this proposal will define the molecular basis for the temperature-dependent gating activity of these ion channels, for ligand recognition, and for the action of modulators. These advances, in turn, will provide a foundation for developing new therapeutic agents against cardiovascular diseases and diabetes and for a deeper understanding of the function of the temperature-sensitive TRPM family members.